- Home
- LYTS vs RAPT Comparison
LYTS vs RAPT Comparison
Compare LYTS & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LYTS | RAPT |
|---|---|---|
| Founded | 1976 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 601.0M | 498.4M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | LYTS | RAPT |
|---|---|---|
| Price | $18.82 | $35.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $27.50 | ★ $57.00 |
| AVG Volume (30 Days) | 131.1K | ★ 469.6K |
| Earning Date | 01-22-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | ★ 2.57 | N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $592,531,000.00 | N/A |
| Revenue This Year | $6.26 | N/A |
| Revenue Next Year | $7.45 | N/A |
| P/E Ratio | $23.73 | ★ N/A |
| Revenue Growth | ★ 22.35 | N/A |
| 52 Week Low | $13.77 | $5.67 |
| 52 Week High | $25.50 | $42.39 |
Technical Indicators
Market Signals| Indicator | LYTS | RAPT |
|---|---|---|
| Relative Strength Index (RSI) | 46.86 | 56.26 |
| Support Level | $18.33 | $34.38 |
| Resistance Level | $19.13 | $36.92 |
| Average True Range (ATR) | 0.42 | 2.56 |
| MACD | 0.10 | -0.11 |
| Stochastic Oscillator | 40.20 | 50.37 |
Price Performance
Historical ComparisonAbout LYTS LSI Industries Inc.
LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Display solutions segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets, including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells, and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.